The WACC of N4 Pharma PLC (N4P.L) is 5.5%.
| Range | Selected | |
| Cost of equity | 5.70% - 7.80% | 6.75% |
| Tax rate | 12.40% - 14.70% | 13.55% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.0% - 6.0% | 5.5% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.28 | 0.4 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.70% | 7.80% |
| Tax rate | 12.40% | 14.70% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.0% | 6.0% |
| Selected WACC | 5.5% | |